Avience Biomedicals Ltd vs Max Healthcare Institute Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 253.15 as of 30 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Max Healthcare Institute Ltd changed from 55.6 on March 2022 to 64.9 on March 2026 . This represents a CAGR of 3.14% over 5 years The Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Max Healthcare Institute Ltd changed from ₹ 19903 crore on March 2021 to ₹ 93581 crore on March 2026 . This represents a CAGR of 29.43% over 6 years The revenue of Avience Biomedicals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Max Healthcare Institute Ltd for the Sep '26 is ₹ 2610 crore as compare to the Jun '26 revenue of ₹ 2406 crore. This represent the growth of 8.45% The ebitda of Avience Biomedicals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Max Healthcare Institute Ltd for the Sep '26 is ₹ 752.39 crore as compare to the Jun '26 ebitda of ₹ 638.97 crore. This represent the growth of 17.75% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Max Healthcare Institute Ltd changed from ₹ 236.27 crore to ₹ 414.45 crore over 10 quarters. This represents a CAGR of 25.21% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Max Healthcare Institute Ltd changed from 13.98 % on March 2023 to 27.16 % on March 2026 . This represents a CAGR of 18.06% over 4 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Max Healthcare Institute Ltd

Max Healthcare Institute Limited was originally incorporated as 'Infinitum Technologies Private Limited' at New Delhi, India as a Private Limited Company dated June 18 ,2001.
Pursuant to a fresh Certificate of Incorporation dated June 28, 2002, the name of Infinitum Technologies Private Limited' was changed to Max Healthcare Institute Private Limited'.
Thereafter, dated October 18, 2002, the Company had changed the name to Max Healthcare Institute Limited'.
The Company is primarily engaged in provision of healthcare services through primary care clinics, multi speciality hospitals / medical centres and superspecialty Hospitals facilities. The Company is a leading hospital chains in India with major concentration in North India consisting of a network of 22 network healthcare facilities, which includes BLK Hospital and BNH Hospital.

FAQs for the comparison of Avience Biomedicals Ltd and Max Healthcare Institute Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Max Healthcare Institute Ltd?

Market cap of Avience Biomedicals Ltd is 138 Cr while Market cap of Max Healthcare Institute Ltd is 83,704 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Max Healthcare Institute Ltd?

The stock performance of Avience Biomedicals Ltd and Max Healthcare Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Max Healthcare Institute Ltd?

As of October 31, 2026, the Avience Biomedicals Ltd stock price is INR ₹253.15. On the other hand, Max Healthcare Institute Ltd stock price is INR ₹860.0.

How do dividend payouts of Avience Biomedicals Ltd and Max Healthcare Institute Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Max Healthcare Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.